Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5277853
Max Phase: Preclinical
Molecular Formula: C12H18N2O
Molecular Weight: 206.29
Associated Items:
ID: ALA5277853
Max Phase: Preclinical
Molecular Formula: C12H18N2O
Molecular Weight: 206.29
Associated Items:
Canonical SMILES: CCCCCc1ccc(N/C=N/O)cc1
Standard InChI: InChI=1S/C12H18N2O/c1-2-3-4-5-11-6-8-12(9-7-11)13-10-14-15/h6-10,15H,2-5H2,1H3,(H,13,14)
Standard InChI Key: INJQGDLSZXJALO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 206.29 | Molecular Weight (Monoisotopic): 206.1419 | AlogP: 3.25 | #Rotatable Bonds: 6 |
Polar Surface Area: 44.62 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.66 | CX Basic pKa: 2.43 | CX LogP: 3.46 | CX LogD: 3.46 |
Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.25 | Np Likeness Score: -0.33 |
1. Yuan Y, Yao H, Zhou M, Ma X, Zhou Y, Xu J, Niu M, Yin J, Zheng L, Xu S.. (2022) Identification of a Novel Potent CYP4Z1 Inhibitor Attenuating the Stemness of Breast Cancer Cells through Lead Optimization., 65 (23.0): [PMID:36414390] [10.1021/acs.jmedchem.2c01320] |
Source(1):